SANUWAVE Health, Inc. (SNWV)
USD 29.96
(2.29%)
USD 29.96
(2.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 30.14 Million USD | -24.54% |
| 2022 | 39.95 Million USD | 56.17% |
| 2021 | 25.58 Million USD | 68.96% |
| 2020 | 15.14 Million USD | 193.22% |
| 2019 | 5.16 Million USD | -50.48% |
| 2018 | 10.42 Million USD | 96.07% |
| 2017 | 5.31 Million USD | -1.3% |
| 2016 | 5.38 Million USD | 3.71% |
| 2015 | 5.19 Million USD | 184.56% |
| 2014 | 1.82 Million USD | 3023.53% |
| 2013 | 58.44 Thousand USD | -84.5% |
| 2012 | 377.07 Thousand USD | 109.68% |
| 2011 | -3.89 Million USD | -142.34% |
| 2010 | 9.2 Million USD | 29.58% |
| 2009 | 7.1 Million USD | 19211.5% |
| 2008 | 36.77 Thousand USD | 814.2% |
| 2007 | -5149.00 USD | 81.08% |
| 2006 | -27.22 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 27.93 Million USD | -7.34% |
| 2024 Q2 | 30.49 Million USD | 9.17% |
| 2023 FY | 30.14 Million USD | -24.54% |
| 2023 Q1 | 39.84 Million USD | -0.28% |
| 2023 Q2 | 45.05 Million USD | 13.08% |
| 2023 Q4 | 30.14 Million USD | -18.12% |
| 2023 Q3 | 36.81 Million USD | -18.28% |
| 2022 Q3 | 31.2 Million USD | 43.73% |
| 2022 Q4 | 39.95 Million USD | 28.03% |
| 2022 FY | 39.95 Million USD | 56.17% |
| 2022 Q1 | 25.04 Million USD | -2.11% |
| 2022 Q2 | 21.71 Million USD | -13.31% |
| 2021 Q4 | 25.58 Million USD | 7.23% |
| 2021 FY | 25.58 Million USD | 68.96% |
| 2021 Q1 | 18.63 Million USD | 23.06% |
| 2021 Q2 | 21.69 Million USD | 16.41% |
| 2021 Q3 | 23.85 Million USD | 10.0% |
| 2020 Q4 | 15.14 Million USD | 25.52% |
| 2020 Q2 | 7.48 Million USD | 39.29% |
| 2020 Q3 | 12.06 Million USD | 61.23% |
| 2020 FY | 15.14 Million USD | 193.22% |
| 2020 Q1 | 5.37 Million USD | 4.03% |
| 2019 Q2 | 12.32 Million USD | 2.55% |
| 2019 Q4 | 5.16 Million USD | -35.18% |
| 2019 FY | 5.16 Million USD | -50.48% |
| 2019 Q1 | 12.01 Million USD | 15.26% |
| 2019 Q3 | 7.96 Million USD | -35.36% |
| 2018 Q1 | 7.58 Million USD | 42.55% |
| 2018 Q4 | 10.42 Million USD | 22.34% |
| 2018 Q3 | 8.52 Million USD | 8.19% |
| 2018 FY | 10.42 Million USD | 96.07% |
| 2018 Q2 | 7.87 Million USD | 3.93% |
| 2017 FY | 5.31 Million USD | -1.3% |
| 2017 Q4 | 5.31 Million USD | 1.43% |
| 2017 Q3 | 5.24 Million USD | -9.53% |
| 2017 Q2 | 5.79 Million USD | 7.91% |
| 2017 Q1 | 5.37 Million USD | -0.32% |
| 2016 Q1 | 4.85 Million USD | -6.64% |
| 2016 FY | 5.38 Million USD | 3.71% |
| 2016 Q4 | 5.38 Million USD | 11.02% |
| 2016 Q3 | 4.85 Million USD | -8.9% |
| 2016 Q2 | 5.32 Million USD | 9.83% |
| 2015 Q4 | 5.19 Million USD | 10.14% |
| 2015 Q1 | 2.91 Million USD | 59.86% |
| 2015 Q2 | 3.72 Million USD | 27.49% |
| 2015 FY | 5.19 Million USD | 184.56% |
| 2015 Q3 | 4.71 Million USD | 26.77% |
| 2014 Q4 | 1.82 Million USD | 166.32% |
| 2014 FY | 1.82 Million USD | 3023.53% |
| 2014 Q2 | -6.15 Million USD | -231.35% |
| 2014 Q1 | -1.85 Million USD | -3276.35% |
| 2014 Q3 | 685.52 Thousand USD | 111.14% |
| 2013 Q2 | 2 Million USD | 986.78% |
| 2013 FY | 58.44 Thousand USD | -84.5% |
| 2013 Q3 | -292.16 Thousand USD | -114.55% |
| 2013 Q4 | 58.44 Thousand USD | 120.01% |
| 2013 Q1 | -226.35 Thousand USD | -160.03% |
| 2012 Q1 | -2.4 Million USD | 38.15% |
| 2012 FY | 377.07 Thousand USD | 109.68% |
| 2012 Q4 | 377.07 Thousand USD | 207.37% |
| 2012 Q3 | -351.2 Thousand USD | 74.73% |
| 2012 Q2 | -1.38 Million USD | 42.32% |
| 2011 Q2 | -2.4 Million USD | -132.13% |
| 2011 FY | -3.89 Million USD | -142.34% |
| 2011 Q1 | 7.47 Million USD | -18.79% |
| 2011 Q4 | -3.89 Million USD | -846.21% |
| 2011 Q3 | -411.73 Thousand USD | 82.85% |
| 2010 Q4 | 9.2 Million USD | 334.55% |
| 2010 Q1 | -64.13 Thousand USD | -100.9% |
| 2010 FY | 9.2 Million USD | 29.58% |
| 2010 Q2 | -277.25 Thousand USD | -332.3% |
| 2010 Q3 | 2.11 Million USD | 863.82% |
| 2009 FY | 7.1 Million USD | 19211.5% |
| 2009 Q4 | 7.1 Million USD | 32.44% |
| 2009 Q3 | 5.36 Million USD | 1540938.51% |
| 2009 Q2 | -348.00 USD | 88.9% |
| 2009 Q1 | -3136.00 USD | -108.53% |
| 2008 Q1 | -2359.00 USD | 54.19% |
| 2008 FY | 36.77 Thousand USD | 814.2% |
| 2008 Q2 | -6829.00 USD | -189.49% |
| 2008 Q3 | 36.68 Thousand USD | 637.18% |
| 2008 Q4 | 36.77 Thousand USD | 0.25% |
| 2007 FY | -5149.00 USD | 81.08% |
| 2007 Q4 | -5149.00 USD | 0.0% |
| 2006 FY | -27.22 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | -103.331% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -13817.769% |
| Polarean Imaging plc | -5.94 Million USD | 606.967% |
| Avitar, Inc. | 5.17 Million USD | -482.984% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 5074.752% |
| AVITA Medical, Inc. | -26.23 Million USD | 214.926% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 430771.429% |
| Össur hf. | 395.08 Million USD | 92.369% |
| Zecotek Photonics Inc. | 2.76 Million USD | -991.314% |
| QHSLab, Inc. | 1.72 Million USD | -1642.631% |
| Wellstar International, Inc. | 51.36 Million USD | 41.31% |
| Össur hf. | 395.08 Million USD | 92.369% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 752.932% |
| Escalon Medical Corp. | 315.68 Thousand USD | -9449.679% |
| Aurora Spine Corporation | 1.9 Million USD | -1480.317% |
| BrainsWay Ltd. | -10.32 Million USD | 392.122% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -1148.31% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -66.319% |
| Vivos Inc. | -1.59 Million USD | 1993.314% |
| MicroPort Scientific Corporation | 673.58 Million USD | 95.524% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -6086.119% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 5672.603% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -4609.019% |
| Nanomix Corporation | 11.38 Million USD | -164.699% |
| Theraclion SA | -5.86 Million EUR | 614.056% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -656.42% |
| Positron Corporation | 1.68 Million USD | -1687.145% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -1771.506% |
| Lombard Medical, Inc. | 11.49 Million USD | -162.262% |
| ALR Technologies Inc. | 19.14 Million USD | -57.44% |
| Stratec SE | 119.12 Million USD | 74.693% |
| Vycor Medical, Inc. | 1.05 Million USD | -2763.08% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -54717.711% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -32248.649% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 318.658% |
| VMS Rehab Systems, Inc. | 133.52 USD | -22578539.904% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -1955.012% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -4678.268% |
| Odyssey Group International, Inc. | 2.1 Million USD | -1330.262% |
| United American Healthcare Corporation | -9.32 Million USD | 423.223% |
| ECGI Holdings, Inc. | 3.17 Million USD | -850.637% |
| Capital Group Holdings, Inc. | -3508.00 USD | 859478.563% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -11379.411% |
| Urologix, Inc. | 4.61 Million USD | -553.239% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -616.179% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -804.976% |
| SS Innovations International, Inc. | 1.18 Million USD | -2443.31% |
| Qualis Innovations, Inc. | 6671.00 USD | -451811.258% |
| Smith & Nephew plc | 2.77 Billion USD | 98.915% |
| NIOX Group Plc | -23.93 Million USD | 225.967% |
| Fuse Medical, Inc. | 1.75 Million USD | -1617.293% |
| Broncus Holding Corporation | -81.42 Million USD | 137.024% |
| Brain Scientific Inc. | 2.11 Million USD | -1324.871% |
| Pressure BioSciences, Inc. | 22.67 Million USD | -32.94% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -76111.543% |